Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 11 recruiting now later-stage tilt

Bradycardia: later-stage trial registry

11 of 30 indexed Bradycardia trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #519 of 28,707 conditions by registered trial count.

30 US clinical trials · 11 currently recruiting · #519 of 28,707 conditions by registered trial count

Bradycardia: 30 US clinical trials tracked, 11 recruiting.

Bradycardia is the subject of 30 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Abbott Medical Devices, running 8 of these trials.

Enrollment posture brief

Registry condition bradycardia

OPEN 11 | RECR 37% | LATE 3 | EARLY 0 | RANK #519 | SPON 8

Nearest open-share peer: Bariatric Surgery Candidate (37% recruiting · 30 trials)

AML60%Acute Myeloid Leukemia40%Bradycardia (this)37%Anatomic Stage IA Breast Can26.7%Adult Acute Myeloid Leukemia0%
Open-enrollment share among volume-matched conditions near Bradycardia

Bradycardia lists 11 open slots (37% of 30 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Bradycardia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Bradycardia is recruiting below its size-band peers.

    11 of 30 indexed trials (36.7%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Bradycardia research.

    Abbott Medical Devices accounts for 8 of 30 trials (26.7%). 12 distinct sponsors appear on at least one study for this condition label.

  3. Typical Bradycardia enrolment sits around 860 participants.

    Median target enrolment is 860 among the 30 trials that report a genuine target (sentinel values excluded). 6 of those (20%) plan for fewer than 100 participants.

  4. Bradycardia research leans observational.

    12 interventional and 18 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 31Phase 42

Open and recent trials

30 total, page 1 of 1

RECRUITING 20,000 participants

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Medtronic

NCT00271180

RECRUITING 8,744 participants

Aveir VR Coverage With Evidence Development Post-Approval Study

Abbott Medical Devices

NCT05336877

RECRUITING 4,000 participants

The Alaska Oculocardiac Reflex Study

Alaska Blind Child Discovery

NCT04353960

RECRUITING 2,812 participants

AVEIR DR Coverage With Evidence Development (CED) Study

Abbott Medical Devices

NCT05932602

RECRUITING 2,100 participants

Aveir VR Real-World Evidence Post-Approval Study

Abbott Medical Devices

NCT05270499

RECRUITING 1,805 participants

Aveir DR Real-World Evidence Post-Approval Study

Abbott Medical Devices

NCT05935007

RECRUITING 586 participants

Aveir AR Coverage With Evidence Development (CED) Study

Abbott Medical Devices

NCT06100770

RECRUITING 360 participants

Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)

VDI Technologies

NCT06641362

RECRUITING 80 participants

His Bundle Pacing in Bradycardia and Heart Failure

Yong-Mei Cha

NCT03008291

RECRUITING NA 34 participants

The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants

Case Western Reserve University

NCT05298748

RECRUITING NA 25 participants

Augmented Pacing for Shock in the Cardiac Intensive Care Unit

Vanderbilt University Medical Center

NCT06713668

ACTIVE NOT RECRUITING 37,000 participants

Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers

Medtronic

NCT03039712

ACTIVE NOT RECRUITING 37,000 participants

Longitudinal Coverage With Evidence Development Study on Micra AV Leadless Pacemakers (Micra AV CED)

Medtronic

NCT04235491

ACTIVE NOT RECRUITING 3,100 participants

Micra Transcatheter Pacing System Post-Approval Registry

Medtronic

NCT02536118

ACTIVE NOT RECRUITING 1,000 participants

Cardiac Implantable Electronic Device (CIED) Research Study

Medtronic Cardiac Rhythm and Heart Failure

NCT05061862

ACTIVE NOT RECRUITING NA 464 participants

Aveir DR i2i Study

Abbott Medical Devices

NCT05252702

ACTIVE NOT RECRUITING NA 326 participants

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

Abbott Medical Devices

NCT04559945

ACTIVE NOT RECRUITING 232 participants

Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring

Everbeat

NCT06892938

ACTIVE NOT RECRUITING NA 192 participants

BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S

Biotronik

NCT06540079

COMPLETED 2,927 participants

MEDTRONIC ADAPTA, VERSA AND SENSIA nEw3 POST APPROVAL STUDY

Medtronic

NCT01076374

COMPLETED Phase 4 1,491 participants

Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response

Biotronik

NCT00355797

COMPLETED Phase 4 950 participants

ULTRA Study for Pacemaker Patients

Boston Scientific Corporation

NCT00133289

COMPLETED 950 participants

VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies

Medtronic Cardiac Rhythm and Heart Failure

NCT00294034

COMPLETED NA 860 participants

CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse

Medtronic Cardiac Rhythm and Heart Failure

NCT00275769

COMPLETED NA 484 participants

EMRI SureScan™ Clinical Study

Medtronic Cardiac Rhythm and Heart Failure

NCT00433654

COMPLETED Phase 3 200 participants

SITELINE 2 Polyurethane

Boston Scientific Corporation

NCT00180284

COMPLETED 117 participants

Patient Preferences for Leadless Pacemakers

Abbott Medical Devices

NCT05327101

COMPLETED 73 participants

Model 4965 Post-Approval Study

Medtronic

NCT01076348

COMPLETED NA 37 participants

Feasibility Study of Remote Support for Implantable Pulse Generator (IPG)/Implantable Cardioverter Defibrillator (ICD) Implant

Medtronic Cardiac Rhythm and Heart Failure

NCT01809652

COMPLETED NA 20 participants

ECG Belt to Assess Electrical Synchronization

Pugazhendhi Vijayaraman

NCT04583709

Phase Distribution

PhaseTrial count
Phase 3 1
Phase 4 2

Named interventions

Most-linked intervention names on Bradycardia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Aveir DR Leadless Pacemaker System Device
3 trials
Aveir VR Leadless Pacemaker System Device
3 trials
Pacemaker Device
2 trials
Remote Implant Support Capability Other
1 trials
Patient Preference Survey Other
1 trials
ECG Belt Device
1 trials
Non-rate adaptive (DDD) pacing Device
1 trials
Standard Rate Adaptive (R) Technology Device
1 trials

US sites by state

Facility locations filed on Bradycardia trials. A trial with sites in several states counts in each.

California 17 trials
Florida 10 trials
Arizona 9 trials
Georgia 8 trials
Alabama 7 trials
Massachusetts 6 trials
Illinois 6 trials
Colorado 6 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Bradycardia page

30 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bradycardia condition card totals 30 registered trials; most-linked intervention Aveir DR Leadless Pacemaker System; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.